Good results put MorphoSys back on acquisition trail

Wednesday 28 July 2010

The antibody business of MorphoSys AG generated a substantial increase in sales and profits for the quarter and half year ended June 2010, giving it an unusual problem of how best to deploy its large cash holdings.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany